SIX2 and colorectal carcinoma: We found that nine key EMT-RDGs were closely associated with the metastasis of CRC, and first proposed that TBX5, FGF8, NOG, SIX2, and TCF15 are the role and potential of EMT-RDGs as prognostic markers and therapeutic targets in CRC.